Negative correlations of psychological distress with quality of life and immunotherapy efficacy in patients with advanced NSCLC.
Year: 2022
Type: article
Study design: Observational Study
Abstract: =14.131, P<0.05). The progression-free survival (PFS) of advanced NSCLC patients who received comprehensive immunotherapy and had no psychological distress was significantly better than that of the psychological distress group (HR, 0.338; 95% CI, 0.192-0.592; P<0.05). The PFS of advanced NSCLC patients who received immunotherapy combined with chemotherapy in the no psychological distress group was significantly better than that in the psychological distress group (HR, 0.458; 95% CI, 0.296-0.709; P<0.05). Psychological distress in advanced NSCLC patients affects the efficacy of immunotherapy, and psychological distress is negatively correlated with quality of life during immunotherapy.
Source: PubMed Central
Authors: Ziran Bi, Wen Li, Jie Zhao, Lulian Pang, Yanyan Jing, Xiuqing Zhang, Senbang Yao, Xiangxiang Yin, He Zuo, Huaidong Cheng
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4226095045